Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.24Price to Sales
VS
Market
Sector
Industry
History
$ 5.27Close
$ 3.92 - $ 5.46 52-Week Range
Ticker Information
Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVANDA PHARMACEUTICALS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VNDA - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 251.72M | 1.24 | $ 203.47M |
| 3/31/2025 | $ 248.7M | 1.24 | $ 201.35M |
| 12/31/2024 | $ 257.76M | 1.3 | $ 198.77M |
| 9/30/2024 | $ 292.71M | 1.53 | $ 190.86M |
| 6/30/2024 | $ 328.75M | 1.81 | $ 182.02M |
| 3/31/2024 | $ 291.57M | 1.64 | $ 177.6M |
| 12/31/2023 | $ 234.18M | 1.22 | $ 192.64M |
| 9/30/2023 | $ 194.46M | 0.92 | $ 211.85M |
| 6/30/2023 | $ 341.6M | 1.43 | $ 238.35M |
| 3/31/2023 | $ 367.07M | 1.43 | $ 256.69M |
Key Performance Insights, Last 5 Years
- VANDA PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/S stands at 2.49.
- Over the past 5 years, VANDA PHARMACEUTICALS INC's average P/S has been 2.13.
- The median P/S for VANDA PHARMACEUTICALS INC during this period was 1.72
- VANDA PHARMACEUTICALS INC reached its highest P/S over the past 5 years at 4.13.
- The lowest P/S recorded by VANDA PHARMACEUTICALS INC in the same timeframe 0.92
VANDA PHARMACEUTICALS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for VANDA PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 601.06M ] / Revenues [ $ 241.44M ]
(=) P/S [ 2.49 ] VNDA - Price to Sales, Last 5 years
0.92
Minimum
Sep 30, 2023
4.13
Maximum
Dec 31, 2020
2.13
Average
1.72
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |